https://walletinvestor.com/stock-forecast/matn-stock-prediction
Mateon Therapeutics Stock Forecast, "MATN" Share Price Prediction Charts
Is "Mateon Therapeutics, Inc" a Good Investment? Current price today: ?0.130 USD (+0.000001%)
History
Forecast
Charts
Data
Market
Q&A
Comments
Current Price ?0.130 USD,1-Year Forecast *?44.782 USD
7 Days Forecast
Get It Now!
1-Year Forecast *
?44.782 USD
Historical index on US Stock Market : E "Should I invest in Mateon Therapeutics stock?" "Should I trade "MATN" stock today?" According to our live Forecast System, Mateon Therapeutics, Inc stock is an awesome long-term (1-year) investment*. "MATN" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "MATN" projections.
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Mateon Therapeutics, Inc. If you are looking for stocks with good return, Mateon Therapeutics, Inc stock can be a profitable 1-year investment option. Mateon Therapeutics, Inc real time quote is equal to 0.130 USD at 2020-03-25, but your current investment may be devalued in the future.
Note: due to the specific nature of Mateon Therapeutics, Inc stock, the estimate can be significantly excessive / unrealistic!
Recent OTLC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:00:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 01:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 02:30:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:00:34 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/13/2023 01:25:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 01:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 01:25:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM